Division of Critical Care, Stamford Hospital, Columbia University College of Physicians and Surgeons, 190 West Broad Street, Stamford, CT 06902, USA.
Crit Care. 2011 Jul 25;15(4):R173. doi: 10.1186/cc10322.
Severe hypoglycemia (blood glucose concentration (BG) < 40 mg/dL) is independently associated with an increased risk of mortality in critically ill patients. The association of milder hypoglycemia (BG < 70 mg/dL) with mortality is less clear.
Prospectively collected data from two observational cohorts in the USA and in The Netherlands, and from the prospective GLUCONTROL trial were analyzed. Hospital mortality was the primary endpoint.
We analyzed data from 6,240 patients: 3,263 admitted to Stamford Hospital (ST), 2,063 admitted to three institutions in The Netherlands (NL) and 914 who participated in the GLUCONTROL trial (GL). The percentage of patients with hypoglycemia varied from 18% to 65% among the different cohorts. Patients with hypoglycemia experienced higher mortality than did those without hypoglycemia even after stratification by severity of illness, diagnostic category, diabetic status, mean BG during intensive care unit (ICU) admission and coefficient of variation (CV) as a reflection of glycemic variability. The relative risk (RR, 95% confidence interval) of mortality associated with minimum BG < 40, 40 to 54 and 55 to 69 mg/dL compared to patients with minimum BG 80 to 109 mg/dL was 3.55 (3.02 to 4.17), 2.70 (2.31 to 3.14) and 2.18 (1.87 to 2.53), respectively (all P < 0.0001). The RR of mortality associated with any hypoglycemia < 70 mg/dL was 3.28 (2.78 to 3.87) (P < 0.0001), 1.30 (1.12 to 1.50) (P = 0.0005) and 2.11 (1.62 to 2.74) (P < 0.0001) for the ST, NL and GL cohorts, respectively. Multivariate regression analysis demonstrated that minimum BG < 70 mg/dL, 40 to 69 mg/dL and < 40 mg/dL were independently associated with increased risk of mortality for the entire cohort of 6,240 patients (odds ratio (OR) (95% confidence interval (CI)) 1.78 (1.39 to 2.27) P < 0.0001), 1.29 (1.11 to 1.51) P = 0.0011 and 1.87 (1.46 to 2.40) P < 0.0001) respectively.
Mild hypoglycemia was associated with a significantly increased risk of mortality in an international cohort of critically ill patients. Efforts to reduce the occurrence of hypoglycemia in critically ill patients may reduce mortality.
严重低血糖(血糖浓度(BG)<40mg/dL)与危重病患者的死亡率增加独立相关。轻度低血糖(BG <70mg/dL)与死亡率的关系不太明确。
分析了来自美国和荷兰两个观察性队列以及前瞻性 GLUCONTROL 试验的前瞻性收集数据。医院死亡率是主要终点。
我们分析了来自 6240 名患者的数据:3263 名入住斯坦福德医院(ST),2063 名入住荷兰的三个机构(NL),914 名参加 GLUCONTROL 试验(GL)。不同队列中低血糖患者的比例从 18%到 65%不等。即使在按疾病严重程度、诊断类别、糖尿病状态、入住重症监护病房(ICU)时的平均 BG 和变异系数(CV)分层后,低血糖患者的死亡率也高于无低血糖患者,CV 反映了血糖变异性。与最低 BG 80-109mg/dL 的患者相比,最低 BG<40、40-54 和 55-69mg/dL 的患者的死亡率相关的相对风险(RR,95%置信区间)分别为 3.55(3.02 至 4.17)、2.70(2.31 至 3.14)和 2.18(1.87 至 2.53)(均 P<0.0001)。与任何低血糖<70mg/dL 相关的死亡率 RR 分别为 3.28(2.78 至 3.87)(P<0.0001)、1.30(1.12 至 1.50)(P=0.0005)和 2.11(1.62 至 2.74)(P<0.0001),分别为 ST、NL 和 GL 队列。多变量回归分析表明,最低 BG<70mg/dL、40-69mg/dL 和<40mg/dL 与整个 6240 名患者的死亡率增加独立相关(优势比(OR)(95%置信区间(CI))1.78(1.39 至 2.27)P<0.0001)、1.29(1.11 至 1.51)P=0.0011 和 1.87(1.46 至 2.40)P<0.0001)。
在国际危重病患者队列中,轻度低血糖与死亡率显著增加相关。降低危重病患者低血糖发生率的努力可能会降低死亡率。